"You cannot track HPV types unless you actually test for the types."
In this insightful video, Dr. Diane Harper explains why the detection of genotype-specific persistence beyond HPV 16 & 18 is critical and encourages labs to adopt FDA-approved primary HPV tests with extended genotyping, and clinicians to use the risk-based management strategies by the ASCCP.
Discover our latest articles, webinars, press releases and updates in women's health.
Learn more about our BD Women’s Health solutions
This form is only intended for use by healthcare professionals seeking additional information about BD products and solutions. Patients seeking health and treatment information should contact their healthcare professional and can find additional resources from ACOG and the American Cancer Society.
Do not submit protected health information (PHI) or patient information (PII) through this form. If you do submit PHI or PII, your question may not be answered, as the information will be deleted to protect your privacy.
Register Now
Stay informed with the latest updates from BD Women’s Health.
